PATRICK LOMBARDI: Open Payments
NPI 1750825725 · POINT PLEASANT BORO, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,135 in 78 payments from 17 companies in 2025. Trend: 2023 $4,825 · 2024 $5,808 · 2025 $4,135
Food & beverage: $4,135
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $751 |
| Novartis Pharmaceuticals Corporation | 8 | $611 |
| Incyte Corporation | 7 | $442 |
| UCB, Inc. | 4 | $431 |
| LEO Pharma Inc. | 9 | $322 |
| GENZYME CORPORATION | 5 | $270 |
| Janssen Biotech, Inc. | 3 | $251 |
| Galderma Laboratories, L.P. | 5 | $240 |
| Amgen Inc. | 2 | $213 |
| Journey Medical Corporation | 2 | $164 |
Products named: SKYRIZI, Opzelura, Bimzelx, TREMFYA, NEMLUVIO, ADBRY, OTEZLA, Rhapsido.
Industry payments across NJ — which companies pay providers there.
